MEDIFAST INC

MED Consumer Cyclical Personal Services

MEDIFAST INC’s revenue for fiscal 2025 (year ended December 2025) was $385.8 million, down 36.0% from fiscal 2024. In the quarter to June 2026, revenue fell 27.6%, EPS fell 221.7% and free cash flow grew 115.3%, each against the same quarter a year earlier. Dividend growth for five consecutive years; insiders bought in the last twelve months.

11.88 0.18 −1.49%
Market cap
$134.8M
P/E
0.0×
Fwd P/E
−7.4×
Dividend yield
—
F-score
4/9
Altman Z
4.46
Beneish M
n/a
Dividend safety
57/100

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Revenue
385.79 602.46 1,072.05 1,598.58 1,526.09 934.84 713.67 501.00 301.56 274.53
Revenue Growth
(35.96%) (43.80%) (32.94%) 4.75% 63.25% 30.99% 42.45% 66.14% 9.85% 0.65%
Cost of Revenue
110.60 157.84 296.20 458.16 398.49 237.03 176.81 121.10 73.75 68.87
Gross Profit
275.19 444.62 775.85 1,140.41 1,127.60 697.82 536.86 379.90 227.81 205.66
SG&A Expenses
289.40 441.75 649.45 955.61 911.36 563.66 445.82 310.84 188.18 178.81
Operating Income
(14.21) 2.88 126.40 184.81 216.24 134.16 91.04 69.06 39.63 26.86
Non-operating Income/Expense
8.57 0.91 2.40 (0.75) (0.11) 0.11 1.32 1.49 0.69 0.26
Non-operating Interest Expenses
— — — — — (0.25) 1.00 1.00 1.00 0.28
EBT
(5.64) 3.79 128.80 184.06 216.13 134.27 92.36 70.55 40.33 27.12
Income Tax Provision
13.03 1.70 29.38 40.49 52.10 31.41 14.45 14.76 12.61 9.29
Income after Tax
(18.67) 2.09 99.42 143.57 164.03 102.86 77.92 55.79 27.72 17.84
Dividends (Preferred)
— — 0.00 0.00 — — — 0.00 — —
Net Income Common
(18.67) 2.09 99.42 143.57 164.03 102.86 77.92 55.79 27.72 17.84
EPS (Basic)
(1.70) 0.19 9.13 12.82 14.01 8.74 6.62 4.67 2.32 1.51
EPS (Diluted)
(1.70) 0.19 9.10 12.73 13.89 8.68 6.43 4.62 2.29 1.49
Shares (Basic, Weighted)
10.98 10.93 10.88 11.20 11.71 11.77 11.77 11.95 11.92 11.84
Shares (Diluted, Weighted)
10.98 10.96 10.92 11.28 11.81 11.85 12.12 12.08 12.09 11.95
Gross Margin
71.33% 73.80% 72.37% 71.34% 73.89% 74.65% 75.22% 75.83% 75.54% 74.91%
EBIT Margin
(3.68%) 0.48% 11.79% 11.56% 14.17% 14.35% 12.76% 13.78% 13.14% 9.78%
EBT margin
(1.46%) 0.63% 12.01% 11.51% 14.16% 14.36% 12.94% 14.08% 13.37% 9.88%
Net Profit Margin
(4.84%) 0.35% 9.27% 8.98% 10.75% 11.00% 10.92% 11.14% 9.19% 6.50%
Free Cash Flow Margin
0.32% 2.83% 13.17% 11.13% 3.95% 14.90% 10.40% 11.19% 13.29% (1.25%)
EBITDA
(0.64) 14.79 139.34 195.80 223.14 138.80 96.12 74.07 44.54 32.70
EBIT
(14.21) 2.88 126.40 184.81 216.24 134.16 91.04 69.06 39.63 26.86
Income from Continuous Operations
(18.67) 2.09 99.42 143.57 164.03 102.86 77.92 55.79 27.72 17.84
Consolidated Net Income/Loss
(18.67) 2.09 99.42 143.57 164.03 102.86 77.92 55.79 27.72 17.84
EPS (Basic, from Continuous Ops)
(1.70) 0.19 9.13 12.82 14.01 8.74 6.62 4.67 2.32 1.51
EPS (Basic, Consolidated)
(1.70) 0.19 9.13 12.82 14.01 8.74 6.62 4.67 2.32 1.51
EPS (Diluted, from Cont. Ops)
(1.70) 0.19 9.10 12.73 13.89 8.68 6.43 4.62 2.29 1.49
Shares (Diluted, Average)
10.98 10.93 10.92 11.28 11.81 11.85 12.12 12.08 12.09 11.95
EPS (Diluted, Consolidated)
(1.70) 0.19 9.10 12.73 13.89 8.68 6.43 4.62 2.29 1.49
EBITDA Margin
(0.17%) 2.45% 13.00% 12.25% 14.62% 14.85% 13.47% 14.78% 14.77% 11.91%
Operating Cash Flow Margin
1.78% 4.06% 13.77% 12.17% 6.20% 15.53% 11.81% 12.14% 14.34% 9.23%

Fold the line items

In millions of $ except per-share values · columns are period end dates